181 related articles for article (PubMed ID: 9291179)
21. novH: differential expression in developing kidney and Wilm's tumors.
Chevalier G; Yeger H; Martinerie C; Laurent M; Alami J; Schofield PN; Perbal B
Am J Pathol; 1998 Jun; 152(6):1563-75. PubMed ID: 9626060
[TBL] [Abstract][Full Text] [Related]
22. A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.
Heathcott RW; Morison IM; Gubler MC; Corbett R; Reeve AE
Hum Mutat; 2002 Apr; 19(4):462. PubMed ID: 11933209
[TBL] [Abstract][Full Text] [Related]
23. WT1 and glomerular diseases.
Niaudet P; Gubler MC
Pediatr Nephrol; 2006 Nov; 21(11):1653-60. PubMed ID: 16927106
[TBL] [Abstract][Full Text] [Related]
24. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion.
Little MH; Williamson KA; Mannens M; Kelsey A; Gosden C; Hastie ND; van Heyningen V
Hum Mol Genet; 1993 Mar; 2(3):259-64. PubMed ID: 8388765
[TBL] [Abstract][Full Text] [Related]
25. Germline WT1 mutations in Wilms' tumor patients: preliminary results.
Li FP; Breslow NE; Morgan JM; Ghahremani M; Miller GA; Grundy PE; Green DM; Diller LR; Pelletier J
Med Pediatr Oncol; 1996 Nov; 27(5):404-7. PubMed ID: 8827066
[TBL] [Abstract][Full Text] [Related]
26. Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor.
Tajinda K; Carroll J; Roberts CT
Endocrinology; 1999 Oct; 140(10):4713-24. PubMed ID: 10499530
[TBL] [Abstract][Full Text] [Related]
27. A novel WT1 gene mutation in a chinese girl with denys-drash syndrome.
Wang F; Cai J; Wang J; He M; Mao J; Zhu K; Zhao M; Guan Z; Li L; Jin H; Shu Q
J Clin Lab Anal; 2021 May; 35(5):e23769. PubMed ID: 33942367
[TBL] [Abstract][Full Text] [Related]
28. A novel Wilms' tumor 1 gene mutation in a child with severe renal dysfunction and persistent renal blastema.
Wagner N; Wagner KD; Afanetti M; Nevo F; Antignac C; Michiels JF; Schedl A; Berard E
Pediatr Nephrol; 2008 Sep; 23(9):1445-53. PubMed ID: 18516627
[TBL] [Abstract][Full Text] [Related]
29. The human sex-determining gene SRY is a direct target of WT1.
Hossain A; Saunders GF
J Biol Chem; 2001 May; 276(20):16817-23. PubMed ID: 11278460
[TBL] [Abstract][Full Text] [Related]
30. [Hereditary renal tumors: Wilms' tumor--congenital anomalies' syndrome].
Tsuchida Y; Yokomori K; Choi SH
Nihon Rinsho; 1995 Nov; 53(11):2742-8. PubMed ID: 8538037
[TBL] [Abstract][Full Text] [Related]
31. Outcome of renal transplantation for Wilms' tumor and Denys-Drash syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study.
Kist-van Holthe JE; Ho PL; Stablein D; Harmon WE; Baum MA
Pediatr Transplant; 2005 Jun; 9(3):305-10. PubMed ID: 15910385
[TBL] [Abstract][Full Text] [Related]
32. A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome.
da Silva TE; Nishi MY; Costa EM; Martin RM; Carvalho FM; Mendonca BB; Domenice S
Pediatr Nephrol; 2011 Aug; 26(8):1311-5. PubMed ID: 21559934
[TBL] [Abstract][Full Text] [Related]
33. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
[TBL] [Abstract][Full Text] [Related]
34. Wilms' tumor protein Wt1 is an activator of the anti-Müllerian hormone receptor gene Amhr2.
Klattig J; Sierig R; Kruspe D; Besenbeck B; Englert C
Mol Cell Biol; 2007 Jun; 27(12):4355-64. PubMed ID: 17420277
[TBL] [Abstract][Full Text] [Related]
35. The Wt1+/R394W mouse displays glomerulosclerosis and early-onset renal failure characteristic of human Denys-Drash syndrome.
Gao F; Maiti S; Sun G; Ordonez NG; Udtha M; Deng JM; Behringer RR; Huff V
Mol Cell Biol; 2004 Nov; 24(22):9899-910. PubMed ID: 15509792
[TBL] [Abstract][Full Text] [Related]
36. The role of Wilms' tumor genes.
Hirose M
J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
[TBL] [Abstract][Full Text] [Related]
37. Distinct molecular origins for Denys-Drash and Frasier syndromes.
Poulat F; Morin D; König A; Brun P; Giltay J; Sultan C; Dumas R; Gessler M; Berta P
Hum Genet; 1993 Apr; 91(3):285-6. PubMed ID: 8386697
[TBL] [Abstract][Full Text] [Related]
38. Genotype/phenotype correlations in Wilms' tumor.
Huff V
Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
[TBL] [Abstract][Full Text] [Related]
39. "Molecular genetic analysis of the WT1 gene in patients suspected to have the Denys-Drash syndrome".
Coppes MJ; Clericuzio CL
Med Pediatr Oncol; 1994; 23(4):390. PubMed ID: 8093189
[No Abstract] [Full Text] [Related]
40. A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome.
Little S; Hanks S; King-Underwood L; Picton S; Cullinane C; Rapley E; Rahman N; Pritchard-Jones K
Pediatr Nephrol; 2005 Jan; 20(1):81-5. PubMed ID: 15503171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]